Navigation Links
Marshall Edwards Adds $2 Million in Private Placement
Date:12/29/2011

ical trial of intravenous ME-143 in patients with solid refractory tumors in September 2011 and expects final data from the trial in the second quarter of 2012. The second program is a family of mitochondrial inhibitors that includes lead candidate ME-344. The Company has completed the necessary pre-clinical animal toxicity studies to support submission of an Investigational New Drug (IND) application for ME-344 in the first quarter of 2012. For more information, please visit www.marshalledwardsinc.com.

Under U.S. law, a new drug cannot be marketed until it has been investigated in clinical trials and approved by the FDA as being safe and effective for the intended use. Statements included in this press release that are not historical in nature are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should be aware that our actual results could differ materially from those contained in the forward-looking statements, which are based on management's current expectations and are subject to a number of risks and uncertainties, including, but not limited to, our failure to successfully commercialize our product candidates; costs and delays in the development and/or FDA approval, or the failure to obtain such approval, of our product candidates; uncertainties or differences in interpretation in clinical trial results; our inability to maintain or enter into, and the risks resulting from our dependence upon, collaboration or contractual arrangements necessary for the development, manufacture, commercialization, marketing, sales and distribution of any products; competitive factors; our inability to protect our patents or proprietary rights and obtain necessary rights to third party patents and intellectual property to operate our business; our inability to operate our business without infringing the patents and proprietary rig
'/>"/>

SOURCE Marshall Edwards, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Marshall Edwards Announces Presentation of New Data Showing Activity in Chemotherapy-Resistant Ovarian Cancer Cells
2. Marshall Edwards Receives NASDAQ Notice Of Non-Compliance; Intends To Request Hearing
3. Marshall Edwards to Host Annual Meeting of Stockholders
4. Marshall Edwards Receives Positive Response From NASDAQ
5. Marshall Edwards Announces Publication of Phase II Clinical Trial Results Highlighting Activity of Intravenous Phenoxodiol
6. Marshall Edwards Announces Private Placement
7. Marshall Edwards Announces Closing of Asset Purchase Agreement With Novogen
8. Marshall Edwards Announces Publication of Pre-Clinical Studies in Pancreatic Cancer
9. Marshall Edwards Announces Publication of Pre-Clinical Study Showing Activity in Chemotherapy-Resistant Ovarian Cancer Stem Cells
10. Marshall Edwards Announces FDA Approval of Investigational New Drug Application for Lead Candidate ME-143
11. Marshall Edwards Announces Initiation of Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/19/2014)... -- Henry Schein, Inc. (NASDAQ: HSIC ), the ... to office-based dental, animal health and medical practitioners, announced ... Inc., a leading full-service provider of dental consumables, implants ... into Japan , the world,s 2 ... the number of countries in which the Company operates. ...
(Date:10/18/2014)... 18, 2014  In a policy paper ... the nation,s largest lesbian, gay, bisexual and transgender ... of Truvada for Pre-Exposure Prophylaxis (PrEP). PrEP is ... prevent the spread of a disease or infection ... name anti-HIV drug combination currently approved for PrEP, ...
(Date:10/17/2014)... 17, 2014  Training market researchers to spot ... factor in today,s highly competitive global marketplace. As ... that effectively and efficiently produce high performing analysts, ... Effective training programs can help ... from internal clients by developing analysts who can ...
Breaking Medicine Technology:Henry Schein Enters Japan With Investment in Iwase Dental Supply 2Henry Schein Enters Japan With Investment in Iwase Dental Supply 3Henry Schein Enters Japan With Investment in Iwase Dental Supply 4Henry Schein Enters Japan With Investment in Iwase Dental Supply 5HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 2HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 3Effective Training Programs for Market Research Groups can Boost Overall Organizational Success 2
... LLC today announced the appointment of Erica L. Mann as ... business based in Morristown, NJ, USA, with operations in more ... million.  Ms. Mann also becomes a member of the Bayer ... 14, 2011. Ms. Mann most recently served as ...
... NEW YORK, Feb. 22, 2011 Reportlinker.com announces ... in its catalogue: North American ... This research covers the state ... and restraints for growth, key trends, and end-user ...
Cached Medicine Technology:Erica L. Mann, Former Pfizer Executive, Appointed New President of Bayer HealthCare's Global Consumer Care Division 2Erica L. Mann, Former Pfizer Executive, Appointed New President of Bayer HealthCare's Global Consumer Care Division 3
(Date:10/19/2014)... (PRWEB) October 20, 2014 Recently, ... and announced that JustHost, GoDaddy and HostMonster are ... market. VPS (Virtual Private Server) is the method ... servers, each of which has the appearance and ... That is why the site pays close attention ...
(Date:10/19/2014)... SweetDressy.com, a professional company of women’s dresses and ... evening dresses . All the company’s old and ... discount is up to 66 percent off. , ... fashion field. Its dress specialists are striving to make ... of the world. All the company’s items are unique, ...
(Date:10/19/2014)... Stephen T. Greenberg, M.D., with offices in Woodbury, Southampton and ... as one of Long Island’s best cosmetic surgeons. In ... the best provider for Botox injections. Glisten, his Skin & ... best Laser Treatment center on Long Island.* , The voting ... the contest once per day, per IP address. , Stephen ...
(Date:10/19/2014)... spondylitis is a systemic disease that causes inflammation ... have affected members of the ancient Egyptian royal ... Arthritis & Rheumatology , a journal of the ... finding instead a degenerative spinal condition called diffuse ... from the 18th to early 20th Dynasties. ...
(Date:10/19/2014)... 2014 The federal litigation involving ... move forward in Massachusetts federal court, where more ... the dialysis medication, Bernstein Liebhard LLP reports. ... shows 2,127 claims now filed over GranuFlo and ... U.S. District Court, District of Massachusetts. Plaintiffs in ...
Breaking Medicine News(10 mins):Health News:The Best VPS Hosting Suppliers In The Market Unveiled By Top10BestSEOHosting.com 2Health News:Promotion For Beautiful Long Evening Dresses Launched By SweetDressy.com 2Health News:Dr. Stephen T. Greenberg – Nominated for the 10th Consecutive Year for One of Long Island’s Best Cosmetic Surgeons for 2015 by the Long Island Press 2Health News:Mummy remains refute antiquity of ankylosing spondylitis 2Health News:More than 2,100 GranuFlo Lawsuits Now Filed in Federal Dialysis Drug Litigation, Bernstein Liebhard LLP Reports 2Health News:More than 2,100 GranuFlo Lawsuits Now Filed in Federal Dialysis Drug Litigation, Bernstein Liebhard LLP Reports 3Health News:More than 2,100 GranuFlo Lawsuits Now Filed in Federal Dialysis Drug Litigation, Bernstein Liebhard LLP Reports 4
... Researchers from the Kimmel Cancer Center at Jefferson have ... milk production blocks an oncogene that makes breast cancer ... Research , the researchers discovered that prolactin, a pituitary ... in fact reduces levels of an oncogene called BCL6. ...
... ... -- Basketball great Alonzo Mourning will be featured ... affairs television program that tells the compelling and inspirational stories of real ... nationwide. , Mourning was one of the top professional basketball players ...
... , SAN DIEGO , Feb. 3 ... will not be working in their current job a year from now ... in the next one to three years in a way that would ... contribution to direct patient care by working fewer hours or choosing a ...
... Three-quarters of nurses providing private and public care experienced workplace ... according to study published in the February issue of the ... (92%) said they had been verbally abused, 69% had been ... of 2,354 incidents were reported to the research team, with ...
... ... ... Governance, Risk and Compliance (GRC) leader MetricStream today announced significant growth ... profits. MetricStream’s growth was fueled by companies prioritizing their need to drive business performance by ...
... ... the donation of an amazing 100,000 pounds of medical supplies to the devastated country of ... APR Energy’s ongoing community service programs. , ... Jacksonville, FL (PRWEB) February 3, 2010 -- Following the tragedy of the ...
Cached Medicine News:Health News:'Sharing Miracles' Television Program to Feature Professional Basketball Legend Alonzo Mourning 2Health News:'Sharing Miracles' Television Program to Feature Professional Basketball Legend Alonzo Mourning 3Health News:'Sharing Miracles' Television Program to Feature Professional Basketball Legend Alonzo Mourning 4Health News:'Sharing Miracles' Television Program to Feature Professional Basketball Legend Alonzo Mourning 5Health News:'Sharing Miracles' Television Program to Feature Professional Basketball Legend Alonzo Mourning 6Health News:'Sharing Miracles' Television Program to Feature Professional Basketball Legend Alonzo Mourning 7Health News:'Sharing Miracles' Television Program to Feature Professional Basketball Legend Alonzo Mourning 8Health News:'Sharing Miracles' Television Program to Feature Professional Basketball Legend Alonzo Mourning 9Health News:'Sharing Miracles' Television Program to Feature Professional Basketball Legend Alonzo Mourning 10Health News:'Sharing Miracles' Television Program to Feature Professional Basketball Legend Alonzo Mourning 11Health News:'Sharing Miracles' Television Program to Feature Professional Basketball Legend Alonzo Mourning 12Health News:'Sharing Miracles' Television Program to Feature Professional Basketball Legend Alonzo Mourning 13Health News:Survey: Over 40 Percent of Nurses to Alter Career Path 2Health News:Survey: Over 40 Percent of Nurses to Alter Career Path 3Health News:Survey: Over 40 Percent of Nurses to Alter Career Path 4Health News:Violence is part of the job say nurses as study shows only 1 in 6 incidents are reported 2Health News:Violence is part of the job say nurses as study shows only 1 in 6 incidents are reported 3Health News:MetricStream Achieves Record Revenue Growth in 2009 with Global Customer Adoption of its Enterprise GRC Platform and Solutions 2Health News:MetricStream Achieves Record Revenue Growth in 2009 with Global Customer Adoption of its Enterprise GRC Platform and Solutions 3Health News:MetricStream Achieves Record Revenue Growth in 2009 with Global Customer Adoption of its Enterprise GRC Platform and Solutions 4Health News:APR Energy Launching Haiti Relief Efforts 2Health News:APR Energy Launching Haiti Relief Efforts 3Health News:APR Energy Launching Haiti Relief Efforts 4
Bipolar forceps...
... in vitro Nucleic Acid Hybridization ... Microplate Chemiluminescence for the Qualitative ... Types 6,11,16,18,31,33,35,39,42,43,44,45,51,52,56,58,59 and 68 and ... High-Risk Groups in Cervical Specimens: ...
... radiation protection-0.62mm (+/- .05)Pb lead glass equivelant ... their level of protection, they are incredibly ... on your bridge while hugging your face ... corrective lenses, you can order Leaded Eyeglasses ...
... time in the world, there is a now ... diagnose VVC in female patients. CanDia5® is a ... the Candida antigens almost instantaneously (within 5 minutes) ... There is no similar POC product for VVC ...
Medicine Products: